NAMSA replaced its paper-based system for managing clinical trial documents with Veeva Vault eTMF and has reported that eTMF has reduced the time spent handling files by at least one-third.
NAMSA, a global medical research organization, recently replaced its paper-based system for managing clinical trial documents with Veeva Systems’ Veeva Vault eTMF. The organization has reported that eTMF has reduced the time spent handling files by at least one-third, which the company says lowers costs and frees staff to focus on more value-add work for clients.
Read the full release.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Gilead Shares Final Data from Phase III MYR301 Trial of Bulevirtide in Chronic Hepatitis Delta Virus
May 7th 2025Long-term results from the study show 90% of patients with chronic HDV who achieved undetectable HDV RNA at 96 weeks of treatment remained undetectable for nearly 2 years post-treatment.